Xuesong Li
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 15
- Molecular Biology top 10%
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 9
-
- Ferroptosis and cancer prognosis 16
- Renal cell carcinoma treatment 11
- Oncology top 10%
- Urology top 10%
- Urological Disorders and Treatments 9
-
- Bladder and Urothelial Cancer Treatments 21
- Urinary and Genital Oncology Studies 13
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xuesong Li
111 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 564
- Molecular Biology 805
- Pulmonary and Respiratory Medicine 367
- Oncology 270
- Urology 45
Countries citing papers authored by Xuesong Li
This map shows the geographic impact of Xuesong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesong Li more than expected).
Fields of papers citing papers by Xuesong Li
This network shows the impact of papers produced by Xuesong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesong Li. The network helps show where Xuesong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuesong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 4 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 0 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2022 | 10 | |
| 18 | 2017 | 2 | |
| 19 | 2014 | 88 | |
| 20 | 2008 | 6 |
About Xuesong Li
Xuesong Li is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 124 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (21 papers), Ferroptosis and cancer prognosis (16 papers), Cancer-related molecular mechanisms research (15 papers), Urinary and Genital Oncology Studies (13 papers), Renal cell carcinoma treatment (11 papers), RNA modifications and cancer (9 papers), Urological Disorders and Treatments (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Cancer Research (564 citations), Molecular Biology (805 citations) and Pulmonary and Respiratory Medicine (367 citations). Xuesong Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Liqun Zhou, Yanqing Gong, Shiming He, Anbang He, Zhicong Chen, Yonghao Zhan, Yucai Wu, Bao Guan, Boxing Su and Han Hao. Their work appears in journals such as Nature Communications, PLANT PHYSIOLOGY and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.